Arcadia Biosciences
RKDA
11 hedge funds and large institutions have $90.4K invested in Arcadia Biosciences in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
5.18% less ownership
Funds ownership: 7.29% → 2.11% (-5.2%)
21% less funds holding
Funds holding: 14 → 11 (-3)
49% less capital invested
Capital invested by funds: $178K → $90.4K (-$87.9K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.01K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$223 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$28 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$89.1K |
| 2 |
Renaissance Technologies
New York
|
-$23K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.04K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$20 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $44.2K | – | – | – |
|
2
State Street
Boston,
Massachusetts
| $38.3K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $5.62K | -$5.04K | -1,991 | -53% |
|
|
4
Morgan Stanley
New York
| $1.91K | +$1.01K | +400 | +193% |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $276 | +$223 | +88 | New |
|
6
Group One Trading
Chicago,
Illinois
| $57 | – | – | – |
|
|
7
Bank of America
Charlotte,
North Carolina
| $35 | +$28 | +11 | New |
|
8
US Bancorp
Minneapolis,
Minnesota
| $16 | – | – | – |
|
|
OLVIG
9
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $13 | – | – | – |
|
|
HI
10
Harbour Investments
Madison,
Wisconsin
| $3 | – | – | – |
|
|
SM
11
Sabby Management
Miami Beach,
Florida
| – | -$89.1K | -40,300 | Closed |
|
|
12
Renaissance Technologies
New York
| – | -$23K | -10,453 | Closed |
|
|
13
Wells Fargo
San Francisco,
California
| – | -$20 | -9 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$4 | -2 | Closed |
|
RKDA Hedge Fund Activity: Q2 2024 in Review
11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2024, worth a combined $90.4K — down 49% from $178K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RKDA and 2 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $1.01K. The largest seller was Sabby Management, exiting entirely with an estimated $89.1K sold.
- 11 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2024, down from 14 in Q1 2024.
- Funds reported $90.4K of Arcadia Biosciences stock for Q2 2024, down 49% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q2 2024 and 5 closed out, a net change of -3 holders.
- The largest Arcadia Biosciences buyer in Q2 2024 was Morgan Stanley, an estimated $1.01K added.
- The largest Arcadia Biosciences seller in Q2 2024 was Sabby Management, an estimated $89.1K sold.
Based on aggregated 13F filings for Q2 2024.